{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:10:30Z","timestamp":1791223830342,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/ajg.2013.249","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T07:55:40Z","timestamp":1377590140000},"page":"1869-1876","source":"Crossref","is-referenced-by-count":215,"title":["Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study"],"prefix":"10.14309","volume":"108","author":[{"given":"Tine","family":"Jess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Horv\u00e1th-Puh\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Fallingborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik H","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bent A","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.gastro.2012.04.054","article-title":"Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.","volume":"143","author":"Herrinton","year":"2012","journal-title":"Gastroenterology"},{"key":"R2-13-20210210","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies.","volume":"105","author":"Pedersen","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R3-13-20210210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2012.01.010","article-title":"Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.","volume":"10","author":"Jess","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-13-20210210","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","article-title":"Increased risk of intestinal cancer in Crohns disease: a meta-analysis of population-based cohort studies.","volume":"100","author":"Jess","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R5-13-20210210","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer.","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"R6-13-20210210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders.","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"R7-13-20210210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ibd.20036","article-title":"Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark.","volume":"13","author":"Jess","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R8-13-20210210","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.","volume":"100","author":"Velayos","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R9-13-20210210","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/ajg.2012.198","article-title":"5-Aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations.","volume":"107","author":"Nguyen","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R10-13-20210210","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2011.07.039","article-title":"Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.","volume":"141","author":"Singh","year":"2011","journal-title":"Gastroenterology"},{"key":"R11-13-20210210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/gut.2011.237412","article-title":"Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.","volume":"61","author":"van Schaik","year":"2012","journal-title":"Gut"},{"key":"R12-13-20210210","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"key":"R13-13-20210210","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"R14-13-20210210","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00042737-200606000-00005","article-title":"Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002.","volume":"18","author":"Jacobsen","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R15-13-20210210","first-page":"535","article-title":"The Danish Cancer Registryhistory, content, quality and use.","volume":"44","author":"Storm","year":"1997","journal-title":"Dan Med Bull"},{"key":"R16-13-20210210","first-page":"441","article-title":"The Danish Civil Registration System. A cohort of eight million persons.","volume":"53","author":"Pedersen","year":"2006","journal-title":"Dan Med Bull"},{"key":"R17-13-20210210","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study.","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"R18-13-20210210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2036.2004.01858.x","article-title":"Intestinal and extra-intestinal cancer in Crohns disease: follow-up of a population-based cohort in Copenhagen County, Denmark.","volume":"19","author":"Jess","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-13-20210210","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/1097-0142(19910401)67:7<2015::AID-CNCR2820670731>3.0.CO;2-R","article-title":"Extracolonic malignancies in inflammatory bowel disease.","volume":"67","author":"Ekbom","year":"1991","journal-title":"Cancer"},{"key":"R20-13-20210210","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/0016-5085(94)90807-9","article-title":"Crohns disease and cancer: a population-based cohort study.","volume":"107","author":"Persson","year":"1994","journal-title":"Gastroenterology"},{"key":"R21-13-20210210","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.crohns.2011.04.013","article-title":"Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study.","volume":"5","author":"Katsanos","year":"2011","journal-title":"J Crohns Colitis"},{"key":"R22-13-20210210","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"The burden of inflammatory bowel disease in Europe.","volume":"7","author":"Burisch","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R23-13-20210210","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease.","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R24-13-20210210","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.","volume":"143","author":"Jess","year":"2012","journal-title":"Gastroenterology"},{"key":"R25-13-20210210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.crohns.2010.11.005","article-title":"Risk of colorectal cancer and small bowel adenocarcinoma in Crohns disease: a population-based study from western Hungary 1977-2008.","volume":"5","author":"Lakatos","year":"2011","journal-title":"J Crohns Colitis"},{"key":"R26-13-20210210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ajg.2011.50","article-title":"5-Aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.","volume":"106","author":"Bernstein","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R27-13-20210210","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1002\/ibd.20957","article-title":"Cervical neoplasia risk in IBD: truth or hysteria?","volume":"15","author":"Mahadevan","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R28-13-20210210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000338144","article-title":"Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?","volume":"30","author":"Beaugerie","year":"2012","journal-title":"Dig Dis"},{"key":"R29-13-20210210","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/ajg.2009.745","article-title":"Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study.","volume":"105","author":"Armstrong","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R30-13-20210210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1053\/j.gastro.2011.09.020","article-title":"Thiopurines for inflammatory bowel disease: time to engage with dermatologists?","volume":"141","author":"Jess","year":"2011","journal-title":"Gastroenterology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2013249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2013249","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2013249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201312000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:46:49Z","timestamp":1786542409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201312000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2013.249","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}